Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RMDN2 (Regulator of microtubule dynamics protein 2) is a protein encoded by the human RMDN2 gene and is characterized by multiple coiled-coil domains that enable microtubule binding and regulation of microtubule dynamics during cell division[1][3][4][6][8][9]. The protein is found in the cytosol during interphase and relocalizes to spindle microtubules and spindle poles during mitosis[9]. It is also detected in the Golgi apparatus and other cytoplasmic locations[6][8]. RMDN2 is broadly expressed in human tissues, with notable expression in multiple brain regions, including the temporal lobe[7][2]. Though not considered an established drug target, recent genome-wide association studies have linked genetic variation near RMDN2 to increased tau deposition in Alzheimer’s disease, and its expression is downregulated in Alzheimer’s brain tissue, suggesting a potential, yet not fully defined, role in neurodegenerative disease etiology[2]. There are currently no known drugs that directly target this protein, nor defined mechanisms of action or specific safety concerns reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulator of microtubule dynamics protein 2 (RMDN2).